Biocept Inc (NASDAQ:BIOC) has appointed Raaj Trivedi as vice president of commercial operations. Biocept Inc (NASDAQ:BIOC) stock performance was -9.62% in last session and finished the day at $6.39. Traded volume was 24,173.00million shares in the last session and the average volume of the stock remained 47.03K shares. Biocept Inc (NASDAQ:BIOC) insider ownership is 0.40%.

On March 12, 2014, Recro Pharma, Inc. (NASDAQ:REPH) completed its initial public offering (“IPO”). In relation to such IPO, the Company filed information reflected in a slide presentation as a free writing prospectus on February 13, 2014. Recro Pharma Inc (NASDAQ:REPH) dropped -5.82 percent to $6.65 Thursday on volume of 31,925.00million shares. The intra-day range of the stock was $6.56 to $7.00. Recro Pharma Inc (NASDAQ:REPH) has a market capitalization of $47.51million.

Eagle Pharmaceuticals Inc (NASDAQ:EGRX) announced today that the United States Patent and Trademark Office has granted Patent No. 8,685,460 for the treatment of heat stroke with Eagle’s dantrolene sodium for injectable suspension (“dantrolene”). Eagle Pharmaceuticals Inc (NASDAQ:EGRX)’s stock on Apr 10, 2014 reported a decrease of -5.92% to the closing price of $11.92. Its fifty two weeks range is $11.41 -$16.44. The total market capitalization recorded $165.71million. The overall volume in the last trading session was 95,640.00million shares. In its share capital, EGRX has 13.92million outstanding shares.

Trevena, Inc. (NASDAQ:TRVN), a clinical stage pharmaceutical company focused on the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced financial results for the year ended December 31, 2013. On Thursday, shares of Trevena Inc (NASDAQ:TRVN) dropped -3.97% to close the day at $5.80. Company return on investment (ROI) is 28.80% and its monthly performance is recorded as -37.57%.